Companies: 10,795·Total market cap: $144.5T
Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc.

LYELNASDAQHealthcare● Active
$12.31
+$0.34(+2.84%)
Market Cap$287242611
P/E Ratio
52W High$45
52W Low$8.46
Overview

Lyell Immunopharma, Inc. (LYEL) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · LYEL · as of Mar 12, 2026

Latest filing snapshot

188
-112-37.33%vs prior year

Lyell Immunopharma, Inc. (LYEL) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
188
Change (1Y)
-112
Growth % (1Y)
-37.33%
Revenue / Employee
$191
Net Income / Employee
$-1.46M
Market Cap
$287M

LYEL Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-12188-112-37.33%
2025-03-11300+76+33.93%
2024-02-28224-50-18.25%
2023-02-28274+55+25.11%
2022-03-29219

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Amarin Corporation plc
AMRN
Amarin Corporation plc
275
#2
Editas Medicine, Inc.
EDIT
Editas Medicine, Inc.
246
#3
Allogene Therapeutics, Inc.
ALLO
Allogene Therapeutics, Inc.
226
#4
Lyell Immunopharma, Inc.
LYEL
Lyell Immunopharma, Inc.YOU
188
#5
Cabaletta Bio, Inc.
CABA
Cabaletta Bio, Inc.
161
#6
AC Immune S.A.
ACIU
AC Immune S.A.
133
#7
Aldeyra Therapeutics, Inc.
ALDX
Aldeyra Therapeutics, Inc.
9
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · LYEL peer comparison

About LYEL employees

LYEL Employees · Headcount

Lyell Immunopharma, Inc. (LYEL) employee data is sourced from the annual SEC 10-K filing. As of 2025, Lyell Immunopharma, Inc. had 188 full-time employees globally. Full-time employees only. Global consolidated headcount.

Lyell Immunopharma, Inc. employs 188 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $191, reflecting the company's operational efficiency.

Lyell Immunopharma, Inc.'s workforce decreased by 112 (37.33%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Lyell Immunopharma, Inc.'s revenue per employee of $191 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

LYEL Employees · 5 questions

As of the latest SEC 10-K filing (2025), Lyell Immunopharma, Inc. had 188 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Lyell Immunopharma, Inc. employee counthow many employees does Lyell Immunopharma, Inc. haveLYEL total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-12